ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1109

Differences Between Correlation and Causal Inference in Detecting Predictors of Undefined Crystal Arthropathy in Women

Laura Scagnellato1, Antonio Collesei2, Sonia farah3, Carlomaurizio Montecucco4, Francesca Oliviero5, Bernd raffeiner6, Marta favero5, Amelia Damasco5, doria Andrea5, Fausto Salaffi3 and Roberta Ramonda7, and SIR Study Group on Crystal Arthropaties, 1Rheumatology Unit, University of Padova, Padova, Italy, 2IRCCS Istituto Oncologico Veneto IOV, Padova, Italy, 3Polytechnic University of Marche, Jesi (AN), Italy, 4IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 5University of Padova, Padova, Italy, 6General Hospital of Bolzano, Bolzano, Italy, 7Rheumatology Unit, University of Padova, Italy, Padova, Italy

Meeting: ACR Convergence 2024

Keywords: Access to care, CPPD, gender, gout, Statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Crystal arthropaties, including gout and calcium pyrophosphate deposition disease (CPPD), are prevalent and burdensome conditions. The ALLSTAR model allows the identification of reliable causal, rather than correlational, links between a given set of examinations and the outcome, correcting for clinical confounders and multiple hypotheses testing. The strength of such links is measured through a different metric than p-value, that is the causal effect. : Our primary aim was to characterise the clinical presentation of crystal arthropaties in female patients and define causal predictors of a missing diagnosis through the deployment of a statistically reliable machine learning tool.

Methods: Adult patients presenting with acute mono-oligoarthritis attributed to gout, CPPD or unspecified crystal arthropathy were systematically enrolled in five rheumatologic centres. Clinical data were gathered through a cross-sectional online survey conducted between January 1, 2023, and November 15, 2023. Individuals with a pre-existing diagnosis of any other inflammatory arthropathy were excluded from the analysis. Consequently, a comparative analysis between female and male patients was conducted. We performed a traditional correlational analysis between the presence of performed examinations and the actual diagnosis of undefined crystal arthropathy. Subsequently, we ran ALLSTAR on the same data to assess the significance of previously found correlations against causal relations.

Results: A total of 399 patients were enrolled, including 136 (34%) females, and 263 males. Female patients were found to be significantly older (mean 67.1 years old vs. 63.8, p=0.008) and exhibited a higher prevalence of comorbidities (60.3% vs. 17.2%, p< 0.001). The rate of women who underwent synovial fluid examination (36.8% vs. 18.4%, p=0.001) and X-ray imaging (XR 43.4% vs. 28.7% p=0.004) was significantly higher. However, in 37.5% of cases, female patients did not receive a definitive diagnosis, vs 14% in males. Different models of logistic regression found a plethora of predictors significantly associated with the diagnosis of undefined crystal arthropathy, such as female sex, older age, comorbidities, XR, US scans, and various XR and US findings. Conversely, applying the ALLSTAR tool, we highlight that only the absence of deposits at US examination is the strongest and only causal predictor of an undefinite diagnosis (effect 0.0403). In men, the only predictor of the undefinite diagnosis is the presence of effusion in US scans, even if displaying a much weaker effect than in women (five times weaker, effect 0.0079).

Conclusion: In this multicentre cohort, female patients with crystal arthropathy are frequently complex elderly individuals with comorbidities and a low quality of life. Despite undergoing various examinations, nearly 40% of cases do not receive a definite diagnosis. Applying a causal inference tool we demonstrate that the best predictor for an undefinite diagnosis is the absence of deposits in US scans.


Disclosures: L. Scagnellato: None; A. Collesei: None; S. farah: None; C. Montecucco: None; F. Oliviero: None; B. raffeiner: None; M. favero: None; A. Damasco: None; d. Andrea: AstraZeneca, 2, 6, Bristol-Myers Squibb(BMS), 2, 6, Eli Lilly, 2, 6, Galapagos, 2, 6, GlaxoSmithKlein(GSK), 2, 6, Janssen, 2, 6, Otsuka, 2, 6; F. Salaffi: None; R. Ramonda: AbbVie/Abbott, 6, Eli Lilly, 2, 6, Novartis, 1, 6, Pfizer, 6, UCB, 6.

To cite this abstract in AMA style:

Scagnellato L, Collesei A, farah S, Montecucco C, Oliviero F, raffeiner B, favero M, Damasco A, Andrea d, Salaffi F, Ramonda R. Differences Between Correlation and Causal Inference in Detecting Predictors of Undefined Crystal Arthropathy in Women [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/differences-between-correlation-and-causal-inference-in-detecting-predictors-of-undefined-crystal-arthropathy-in-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-between-correlation-and-causal-inference-in-detecting-predictors-of-undefined-crystal-arthropathy-in-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology